Nilsine Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Buy |
12,613
+10,757
| +580% | +$1.19M | 0.14% | 161 |
|
|
2025
Q1 | $208K | Buy |
+1,856
| New | +$208K | 0.02% | 350 |
|
|
2024
Q2 | – | Sell |
-13,216
| Closed | -$968K | – | 330 |
|
|
2024
Q1 | $968K | Buy |
13,216
+790
| +6% | +$57.9K | 0.13% | 174 |
|
|
2023
Q4 | $1.01M | Buy |
12,426
+532
| +4% | +$43.1K | 0.15% | 164 |
|
|
2023
Q3 | $891K | Buy |
11,894
+127
| +1% | +$9.52K | 0.13% | 173 |
|
|
2023
Q2 | $907K | Buy |
11,767
+30
| +0.3% | +$2.31K | 0.13% | 175 |
|
|
2023
Q1 | $974K | Buy |
+11,737
| New | +$974K | 0.15% | 167 |
|